Past event: Adaptive Clinical Trials Symposium

Ensure Proficient Use of Capital and Resources Through Shorter Timeframes Using Adaptive Design to Allocate Resources More Efficiently Without Lowering Standards

Adaptive clinical trial design allows for modifications to the trial after it begins without damaging the integrity of the study. An adaptive design allows for a more proficient use of capital and resources through shorter timeframes and fewer patients. Using adaptive design sponsor organizations can allocate resources more efficiently without lowering standards and therefore are able to accelerate the clinical development process.

The point at which data is reviewed for an adaptive trial is known as an interim analysis. During the interim analysis, trial organizers review and analyze data before all the "needed" data is collected. This is the pivotal point where an adaptive trial differs from a traditional design. If a sponsor organization notices that something needs to change within their protocol they can make the necessary changes here, without compromising the trial or starting over - ultimately saving time and resources.

The 2nd Adaptive Clinical Trials Symposium will teach cross-functional stakeholders the importance of statistics, data management, and operations through interim analysis for adaptive clinical trials.

Top Five Reasons to Attend

  1. Discover best practices for planning and managing an adaptive trial
  2. Learn, from true industry experiences, how to get drugs to market faster at less cost
  3. Analysis of FDA guidance and tips to navigate through the gray areas associated with an adaptive design
  4. Network with peers and top industry professionals in an intimate environment
  5. Understand the role of interim analysis in adaptive design

Who Should Attend

This conference is designed for representatives from pharmaceutical, biotechnology, clinical research organizations, and clinical sites with responsibilities in the following areas:
  • Biostatistics
  • Clinical Trial Design
  • Clinical/Medical Research
  • Clinical Operations
  • Clinical Supplies
  • Contract Research Organizations
  • Data Management
  • Medical Affairs
  • Patient Recruitment
  • Project Management
  • Regulatory Affairs
  • Drug Development
  • Clinical Development
  • Clinical Studies
  • Clinical Scientists
This conference is also of interest to:
  • Clinical Research Organizations
  • Clinical / Quality Risk Consultants
  • Medical Informatics
  • Business Development
  • Patient Engagement and Retention Services
  • Clinical Technology and Data Management Solution Providers
  • Functional Service Providers

Speakers

  • Nidal Al-Huniti, Executive Director, U.S. Oncology Lead, Quantitative Clinical Pharmacology, ASTRAZENECA
  • Sameer Bansilal, Director Medical Affairs, BAYER
  • Allyson Cage, Ph.D., Chief Medical Officer, COHEN VETERANS BIOSCIENCE
  • Greg Daniel, Deputy Director, DUKE UNIVERSITY
  • Matthew Davis, Head of Global Statistics, TEVA PHARMACEUTICALS
  • Philip Delff, Associate Director of Quantitative Clinical Pharmacology, ASTRAZENECA
  • Chrysanthi Dori, Head Direct Subject Data Acquisition, BAYER
  • Abdel Halim, VP Translational Medicine, Biomarkers and Diagnostics, CELLDEX THERAPEUTICS
  • Donna Jarlenski, Vice President, Clinical Operations, MERSANA THERAPEUTICS
  • Patrick Mitchell, Statistical Science Associate Director, ASTRAZENECA PHARMACEUTICALS
  • Robin Mogg, Clinical Biostatistics Leader, BILL & MELINDA GATES MEDICAL RESEARCH INSTITUTE
  • Macaulay Okwuokenye, Associate Director - HCP Strategy and Promotion, SYROS PHARMACEUTICALS
  • Kinjal Patel, Study Management for Translational Sciences, Research and Development, BAYER USA LLC
  • Rajesh Shukla, VP Clinical Research & Operations, CASTLE CREEK PHARMACEUTICALS
  • Alex Sverdlov, Director, Statistical Scientist, NOVARTIS
  • Rebecca Vanlandingham, Director, Clinical Development, TEVA PHARMACEUTICALS
  • Peter Zhang, Ph.D., Head of Biostatistics, OTSUKA PHARMACEUTICALS

Please fill in your name and email to receive the Symposium Agenda of this event.

Venue

Sonesta Philadelphia Downtown Rittenhouse Square
1800 Market St, 19103
Philadelphia, PA, USA

Venue

Sonesta Philadelphia Rittenhouse Square
1800 Market Street
Philadelphia, PA 19103

Explore the comfort and fresh, contemporary vibe at Sonesta Philadelphia Downtown Rittenhouse Square. A premier choice among hotels in Philadelphia, enjoy spacious, modern accommodations and luxurious amenities while staying in the heart of downtown and only steps away from Rittenhouse Square.

To make reservations, please call 1-800-SONESTA and request the negotiated rate for ExL's March Meetings. To make reservations online: Click Here

The group rate is available until February 27, 2019. Please book your room early, as rooms available at this rate are limited.
Event details
Organizer : ExL
Event type : Conference
Reference : ASDE-19170